Stockreport

Trevi Therapeutics to Participate in Upcoming March Conferences [Yahoo! Finance]

Trevi Therapeutics, Inc.  (TRVI) 
PDF biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients with idiopathic pulmonary f [Read more]